The Next Generation of Glioma Biomarkers: MGMT Methylation, BRAF Fusions and IDH1 Mutations

For some, glioma biomarkers have been expected to solve common diagnostic problems in routine neuropathology service caused by insufficient material, technical shortcomings or lack of experience. Further, biomarkers should predict patient outcome and direct optimal therapy for the individual patient...

Full description

Saved in:
Bibliographic Details
Published in:Brain Pathol
Main Authors: Von Deimling, Andreas, Korshunov, Andrey, Hartmann, Christian
Format: Artigo
Language:Inglês
Published: Blackwell Publishing Ltd 2010
Subjects:
MINI‐SYMPOSIUM: Molecular Diagnostics in Neuro‐Oncology
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8094257/
https://ncbi.nlm.nih.gov/pubmed/21129061
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1750-3639.2010.00454.x
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items